A comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinoma
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 5 (2), 80-84
- https://doi.org/10.1016/s0936-6555(05)80851-9
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- How to Improve Cytotoxic Therapy in Advanced Breast CancerActa Oncologica, 1990
- A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Cancer of the BreastNew England Journal of Medicine, 1980